SANUWAVE Health Inc (SNWV)
0.0212
0.00 (0.00%)
USD |
OTCM |
Apr 25, 09:56
SANUWAVE Health Cash from Financing (TTM): 5.211M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.211M |
September 30, 2023 | 8.076M |
June 30, 2023 | 13.71M |
March 31, 2023 | 14.26M |
December 31, 2022 | 17.38M |
September 30, 2022 | 12.90M |
June 30, 2022 | 6.86M |
March 31, 2022 | 6.479M |
December 31, 2021 | 5.121M |
September 30, 2021 | 4.888M |
June 30, 2021 | 32.51M |
March 31, 2021 | 32.33M |
December 31, 2020 | 33.45M |
September 30, 2020 | 36.57M |
June 30, 2020 | 8.956M |
March 31, 2020 | 9.048M |
December 31, 2019 | 7.86M |
September 30, 2019 | 6.393M |
June 30, 2019 | 4.958M |
March 31, 2019 | 3.082M |
December 31, 2018 | 3.318M |
September 30, 2018 | 2.936M |
June 30, 2018 | 3.166M |
March 31, 2018 | 3.320M |
December 31, 2017 | 2.117M |
Date | Value |
---|---|
September 30, 2017 | 0.9801M |
June 30, 2017 | 2.020M |
March 31, 2017 | 1.826M |
December 31, 2016 | 3.208M |
September 30, 2016 | 3.072M |
June 30, 2016 | 1.703M |
March 31, 2016 | 1.459M |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | -0.0013M |
March 31, 2015 | 0.8973M |
December 31, 2014 | 10.07M |
September 30, 2014 | 10.47M |
June 30, 2014 | 12.13M |
March 31, 2014 | 11.57M |
December 31, 2013 | 4.035M |
September 30, 2013 | 4.090M |
June 30, 2013 | 2.433M |
March 31, 2013 | 2.095M |
December 31, 2012 | 0.4504M |
September 30, 2012 | -0.0045M |
June 30, 2012 | -0.0033M |
March 31, 2012 | 8.465M |
December 31, 2011 | 12.37M |
September 30, 2011 | 14.12M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.888M
Minimum
Sep 2021
36.57M
Maximum
Sep 2020
14.05M
Average
8.956M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
AIM ImmunoTech Inc | 0.485M |
Perspective Therapeutics Inc | 0.785M |
Protalix BioTherapeutics Inc | 24.67M |
Electromed Inc | -0.128M |
Armata Pharmaceuticals Inc | 53.99M |